^○Davide Cossu^1,2, Kazumasa Yokoyama¹, Kyoko Kuwahara Arai³, Yasunobu Hoshino¹, Eiichi Momotani⁴, Nobutaka Hattori¹ (1.Juntendo University School of Medicine, Department of Neurology, Tokyo, Japan, 2.Juntendo University School of Medicine, Advanced Research Institute for Health Science, Tokyo, Japan, 3.Juntendo University School of Medicine, Department of Microbiology, Tokyo, 4.Comparative Medical Research Institute, Laboratory of Immunopathology, Tsukuba)

^○Rieko Nishi¹, Masaki Ohyagi¹, Tetsuya Nagata¹, Yo Mabuchi², Takanori Yokota¹ (1.Department of Neurology and Neurological Science, Tokyo Medical and Dental University, Japan, 2.Department of Biochemistry and Biophysics, Tokyo Medical and Dental University)

^○Michael A. Bonilla, Ryndell G. Alava (St Paul's Hospital Iloilo Philippines, Philippines)

^○Hideo Kihara, Hisao Kitazono, Wataru Hagiwara, Masashi Inoue, Shingo Konno, Toshiki Fujioka (Toho University Medical Center Ohashi Hospital, Japan)

^○Shunsuke Yoshimura¹, Shinsuke Nakagawa², Shuhei Tsujino¹, Kairi Yamashita¹, Takuro Hirayama¹, Kaori Fukushima¹, Rie Ota¹, Tadashi Kanamoto¹, Tomoaki Shima¹, Atsushi Nagaoka¹, Teiichiro Miyazaki¹, Tateishi Yohei¹, Shiraishi Hirokazu¹, Akira Tsujino¹ (1.Department of Neurology and strokology, Nagasaki University Hospital, Japan, 2.Department of Medical Pharmacology, Nagasaki University Institute of Biomedical Sciences)

^○Takuya Matsushita¹, Mitsuru Watanabe¹, Shoko Fukumoto¹, Koji Shinoda¹, Guzailiayi Maimaitijiang¹, Ayako Sakoda¹, Yuri Nakamura¹, Noriko Isobe², Jun-ichi Kira¹ (1.Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurological Therapeutics, Graduate School of Medical Sciences, Kyushu University)

^○Mitsuru Watanabe¹, Eriko Matsuo¹, Guzailiayi Maimaitijiang¹, Koji Shinoda¹, Ayako Sakoda¹, Shoko Fukumoto¹, Yuri Nakamura^1,2, Noriko Isobe³, Fumie Hayashi¹, Katsuhisa Masaki¹, Takuya Matsushita¹, Yasunobu Yoshikai⁴, Jun-ichi Kira¹ (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Japan, 2.Department of Neurology, Fukuoka Central Hospital, International University of Health and Welfare, Fukuoka, Japan, 3.Department of Neurological Therapeutics, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, 4.Division of Host Defense, Medical Institute of Bioregulation, Kyushu University)

^○Ayako Sakoda¹, Takuya Matsushita¹, Mitsuru Watanabe¹, Guzailiayi Maimaitijiang¹, Koji Shinoda¹, Noriko Isobe², Jun-ichi Kira¹ (1.Department of Neurology, Neurological Institute, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan, 2.Department of Neurology, Neurological Therapeutics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)

^○Hirohiko Ono¹, Tatsuro Misu¹, Yuki Matsumoto¹, Chihiro Namatame¹, Yoshiki Takai¹, Shuhei Nishiyama¹, Hiroshi Kuroda¹, Toshiyuki Takahashi^1,2, Ichiro Nakashima³, Kazuo Fujihara⁴, Masashi Aoki¹ (1.Department of Neurology, Tohoku University School of Medicine, Japan, 2.Department of Neurology, Yonezawa National Hospital, 3.Department of Neurology, Tohoku Medical and Pharmaceutical University, 4.Department of Multiple Sclerosis Therapeutics, Fukushima Medical University School of Medicine)